🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Healthy Males

A Pharmacokinetics and Safety Study of Azvudine Tablets in Subjects With Mild-To-Moderate GFR Decline in Renal Insufficiency and in Healthy Subjects NCT07001436Phase 11 site📍 Beijing Henan Genuine Biotech Co., Ltd. · Tests: Azvudine tablets Physical Inactivity and Appetite Regulation NCT06240208NA1 site📍 Copenhagen Copenhagen University Hospital, Rigshospitalet · Tests: Inactivity A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function NCT07315360Phase 14 sites📍 Lake Forest📍 Orlando📍 Tampa Pfizer · Tests: PF-07328948 Plan A Occlusion and Reversal System Feasibility Study NCT07361120Phase 23 sites📍 Maribyrnong📍 St Kilda📍 Hawkesbury Next Life Sciences · Tests: Occlusion System Urinary Microbiome Differences in Bladder Cancer, Benign Urinary Diseases and Healthy Counterparts in Adult Male Population NCT06992986n/a1 site📍 Rome Regina Elena Cancer Institute · Tests: Investigating differences in the bladder microbiome A Phase 1 Study of CLYM116 in Normal Healthy Volunteers NCT07248865Phase 11 site📍 Brisbane Climb Bio, Inc. · Tests: CLYM116, Placebo A Phase 1 Study of Single and Multiple Ascending Doses of GV-100 NCT07788014Phase 11 site📍 Adelaide Gilva Therapeutics Inc. · Tests: GV-100, Placebo A Methodological Study to Learn More About Kidney Function in Healthy People and in People With Reduced Kidney Function NCT07368712NA1 site📍 Berlin Bayer · Tests: No investigational study intervention Study to Assess the Plasma Concentration of Rilzabrutinib Given as a Tablet to Adult Participants With Severe Renal Impairment Compared to Matched Participants With Normal Renal Function NCT07853131Phase 11 site📍 Hialeah Sanofi · Tests: rilzabrutinib To Evaluate the Effect of Food on the Pharmacokinetics of Y-4 Tablets in Healthy Subjects NCT07013773Phase 11 site📍 Beijing Beijing Tiantan Hospital · Tests: Y-4 tablet A Study to Evaluate the Safety, Tolerability and PK of SK-08 NCT07021157Phase 11 site📍 Hangzhou Consun Pharmaceutical Group · Tests: SK-08, Placebo Effects of Lentil Protein Hydrolysate on Blood Pressure Control, Vascular Function and Exercise Performance NCT06894875NA1 site📍 Melbourne Nuritas Ltd · Tests: Lentil protein hydrolysate, Placebo MCC micro-crystalline cellulose Physical Impairments in Children With Chronic Renal Failure NCT06981585n/a1 site📍 Izmir Izmir Democracy University · Tests: Physical Evaluations of Patients with Chronic Kidney Failure, Physical Evaluations of Healthy Children Effect of Probiotics on Appetite Regulation in Adults With Overweight/Obesity NCT07715955NA1 site📍 Maastricht Maastricht University Medical Center · Tests: Probiotic supplementation, Placebo FueL Use During eXercise in Males and Females NCT07829237NA1 site📍 Toronto University of Toronto · Tests: Pre-exercise carbohydrate beverage, Pre-exercise protein beverage, Fasted control beverage A Study to Compare How 2 Different Formulations of Survodutide Are Taken up in the Body When Given by Injection in Healthy Men and Women With and Without Overweight or Obesity NCT07768813Phase 11 site📍 Mannheim Boehringer Ingelheim · Tests: Survodutide formulation A, Survodutide formulation B2 A Study in Healthy Men to Test How Well Different Doses of BI 3776528 Are Tolerated NCT06745297Phase 11 site📍 Berlin Boehringer Ingelheim · Tests: BI 3776528, Placebo matching BI 3776528, short-acting benzodiazepine A Study to Test How Much BI 3034701 Gets Into the Blood in Healthy People When Given in Two Different Ways NCT07837648Phase 11 site📍 Nottingham Boehringer Ingelheim · Tests: BI3034701 formulation II, BI3034701 formulation C1 BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants NCT06741072Phase 11 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Biospecimen Collection, Dulbecco''s Phosphate-Buffered Saline, Peptide Vaccine, QS21 Assessing the Impact of a Leucine Enriched Whey Protein vs Isonitrogenous Whey on Muscle Protein Synthetic Responses in the Rested and Acute Post Exercise States in Older Adults NCT06971822NA1 site📍 Derby University of Nottingham · Tests: Protein Supplementation The Importance of Non-essential Amino Acids for Maintaining Skeletal Muscle Protein Synthesis Rates in Healthy Young Men NCT06687343NA1 site📍 Maastricht Maastricht University Medical Center · Tests: EAA Supplement, NEAA Supplement, Maltodextrin Supplement Clinical Trials of IBI3035 in Healthy Subjects NCT07591519Phase 11 site📍 Chongqing Innovent Biologics (Suzhou) Co. Ltd. · Tests: IBI3035, Insulin icodec Injection A Study to Investigate the Pharmacokinetics, Pharmacodynamics, and Safety of NKF-PEG, and US-Neulasta in Healthy Adult Male Volunteers NCT07738991Phase 11 site📍 Zhengzhou Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. · Tests: NKF-PEG, US-Neulasta Plasma Oxytocin Response to Oral Estrogens in Healthy Controls and AVP-Deficiency NCT07361263NA1 site📍 Basel University Hospital, Basel, Switzerland · Tests: estradiol valerate, esthinylestradiol A Study in Healthy People to Test How Zongertinib is Taken up in the Body When Given as Tablets Made by Two Different Manufacturers With or Without Food NCT07789028Phase 11 site📍 Biberach Boehringer Ingelheim · Tests: Zongertinib, Formulation A, reference product, Zongertinib Formulation B, test product Vasopressin and Pain Perception in the Brain NCT03446456Phase 1, Phase 21 site📍 Baltimore University of Maryland, Baltimore · Tests: Arginine vasopressin, Saline, Observational learning, fMRI data aquisition A Clinical Study to Evaluate the Safety of MF1, a New Treatment for Parkinson's Disease-related Disorders (MF1 Study) NCT07666022Phase 11 site📍 Sumida-ku University of Shizuoka · Tests: MF-1, Placebo Phase 1a Study Assessing Safety, Tolerability, Pharmacokinetics, and Immunogenicity of PMG1016 NCT07615985Phase 11 site📍 Brisbane Pulmongene Ltd. · Tests: PMG1016 Dose 1, PMG1016 Dose 2, PMG1016 Dose 3, PMG1016 Dose 4 A Clinical Trial of Nemtabrutinib in Participants With Severe Kidney Disease (MK-1026-027) NCT07734610Phase 11 site📍 Miami Lakes Merck Sharp & Dohme LLC · Tests: Nemtabrutinib The Voided Urinary, Perineal, and Faecal Microbiota Among Children and Adolescents - the PpUF-study. NCT07535619n/a4 sites📍 Aalborg📍 Aarhus📍 Herning Aalborg University Hospital
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy